The Justice for Incarcerated Moms Act aims to improve maternal health outcomes for pregnant and postpartum individuals in the criminal justice system by restricting financial incentives for states that use restraints on pregnant inmates. Under the bill, states receiving federal justice grants would face a 25 percent funding penalty if they fail to implement laws limiting the use of shackles on pregnant individuals, with those withheld funds redirected to compliant states. The legislation also directs the Bureau of Prisons and the Department of Justice to create and fund programs in at least six federal facilities and across various state and local prisons that provide specialized prenatal care, mental health support, and reentry assistance. These programs are designed to address specific health disparities, particularly for racial and ethnic minority groups, by offering culturally competent care, nutrition counseling, and opportunities to maintain contact with newborn children. Additionally, the act requires an independent oversight organization to monitor program implementation and mandates a Government Accountability Office report to analyze maternal and infant health data within the correctional system.
The Anti-Fraud Fund Act of 2026 increases funding for the Health Care Fraud and Abuse Control Account by $7 billion annually from fiscal year 2027 through 2030. This additional money is intended to support the government's efforts in detecting and preventing fraud within the healthcare system. The bill modifies existing laws to ensure these funds are available for the specified period without altering other spending limits.
The Protection Against Mass Surveillance Act prohibits federal agencies from buying, using, or contracting for automated surveillance systems that rely on license plate recognition, facial recognition, biometric identification, or other technologies designed for mass tracking. It also prevents state, local, and tribal governments from using federal funds to acquire or operate these same surveillance tools. If federal agencies obtain data in violation of these rules, the law requires them to delete the information within 30 days and bars its use as evidence in any court or administrative proceeding.
The RURAL Healthcare Act proposes to reclassify certain temporary healthcare professionals as independent contractors for the purposes of federal labor laws. It specifies that qualified locum tenens professionals and advanced care practitioners, such as physicians, nurse practitioners, and physician's assistants, would not be considered employees under the Fair Labor Standards Act or the National Labor Relations Act. This reclassification applies if they provide temporary services for up to one continuous year at a site and operate under a written contract stating they are not employees. The bill directly affects these healthcare providers and the facilities that contract for their temporary services.
HR 6213, the Heat Workforce Standards Act of 2025, prohibits the U.S. Department of Labor from finalizing, implementing, or enforcing OSHA's proposed "Heat Injury and Illness Prevention" standard (published August 30, 2024). This bill directly blocks the specific regulatory proposal targeting heat safety in both outdoor and indoor work settings. It does not create new requirements or affect workers; it solely prevents the implementation of the existing OSHA proposal. The bill is procedural, focusing on halting a regulatory action rather than establishing new policy.
North Rim Restoration Act This bill allows the National Park Service (NPS) to expedite the approval of contracts to restore forests, structures, and assets within areas of the Grand Canyon National Park impacted by the Dragon Bravo Fire in Arizona. Specifically, the bill authorizes the NPS to use emergency acquisition flexibilities without a presidential emergency or disaster declaration to contract for the following services in such impacted areas: managing or restoring forests, rebuilding structures affected by the fire, improving grounds and structures, conducting recovery efforts, or other specified activities. This authority expires on the date that is the earlier of the following: (1) seven years after the date of this bill's enactment, or (2) the date on which projects and recovery efforts within such area are completed. The NPS may request Congress extend such authority for 12 months if a new wildfire ignites within such area and impacts recovery efforts related to the Dragon Bravo Fire. The bill also authorizes the NPS to enter into noncompetitive procurement contracts for rebuilding, rehabilitating, replacing, or operating assets, such as lodging or utilities, to support the recovery and reopening of the Grand Canyon National Park North Rim. This authority is conditioned upon the NPS making certain determinations regarding the North Rim concessioner and it terminates seven years after this bill's enactment.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
This bill establishes the INCLUDE Project at the National Institutes of Health (NIH) to advance research on Down syndrome and related health conditions. It requires NIH to fund high-risk studies on trisomy 21, support inclusive clinical trials for people with Down syndrome across all ages, and investigate co-occurring conditions like Alzheimer’s disease and autoimmunity. The law mandates NIH coordination across its institutes, consultation with patient advocates, and biennial reports to Congress detailing funded research and its real-world applications. The project directly affects individuals with Down syndrome, their families, and medical researchers, aiming to improve diagnosis, treatment, and quality of life through targeted scientific efforts.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
HR 2001 increases annual funding for a grant program supporting dental workforce development from $13.9 million to $15 million, extending the program through fiscal years 2026-2030 (previously 2019-2023) under the Public Health Service Act. The bill modifies existing funding levels to maintain support for addressing dental workforce shortages, with funds remaining available until expended. This change directly affects the operation of the grant program and its ability to fund dental workforce initiatives.
This bill requires Medicare to create separate payment codes for ultralightweight manual wheelchairs based on their frame material (specifically titanium or carbon fiber vs. other materials), starting in 2026. It ensures Medicare pays the standard rate for titanium/carbon fiber wheelchairs regardless of material, while allowing suppliers to charge beneficiaries the difference between Medicare's payment and their actual cost. Beneficiaries must receive a notice about potential additional costs before purchasing or renting such wheelchairs. The bill directly affects Medicare beneficiaries needing these specialized wheelchairs and the suppliers who provide them.
